GILD logo

Gilead Sciences (GILD) Retained Earnings

Annual Retained Earnings

N/A

December 31, 2024


Summary


Performance

GILD Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherGILDbalance sheetmetrics:

Quarterly Retained Earnings

N/A

December 31, 2024


Summary


Performance

GILD Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherGILDbalance sheetmetrics:

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

GILD Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years--
5 y5 years--

GILD Retained Earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time

Gilead Sciences Retained Earnings History

DateAnnualQuarterly
Sep 2024
-
$11.07 B(-0.8%)
Jun 2024
-
$11.16 B(+4.8%)
Mar 2024
-
$10.66 B(-34.6%)
Dec 2023
$16.30 B(+3.9%)
$16.30 B(+1.9%)
Sep 2023
-
$16.00 B(+5.7%)
Jun 2023
-
$15.14 B(-0.6%)
Mar 2023
-
$15.22 B(-3.0%)
Dec 2022
$15.69 B(-3.9%)
$15.69 B(-0.4%)
Sep 2022
-
$15.76 B(+4.2%)
Jun 2022
-
$15.12 B(+0.9%)
Mar 2022
-
$14.99 B(-8.2%)
Dec 2021
$16.32 B(+13.5%)
$16.32 B(-3.4%)
Sep 2021
-
$16.90 B(+9.8%)
Jun 2021
-
$15.39 B(+3.9%)
Mar 2021
-
$14.82 B(+3.1%)
Dec 2020
$14.38 B(-25.8%)
$14.38 B(+4.9%)
Sep 2020
-
$13.71 B(-5.1%)
Jun 2020
-
$14.45 B(-22.8%)
Mar 2020
-
$18.71 B(-3.5%)
Dec 2019
$19.39 B(+1.9%)
$19.39 B(+10.1%)
Sep 2019
-
$17.62 B(-11.2%)
Jun 2019
-
$19.83 B(+2.6%)
Mar 2019
-
$19.33 B(+1.6%)
Dec 2018
$19.02 B(+0.1%)
$19.02 B(-8.1%)
Sep 2018
-
$20.71 B(+4.4%)
Jun 2018
-
$19.82 B(+3.3%)
Mar 2018
-
$19.20 B(+1.0%)
Dec 2017
$19.01 B(+4.7%)
$19.01 B(-19.7%)
Sep 2017
-
$23.69 B(+8.6%)
Jun 2017
-
$21.82 B(+11.5%)
Mar 2017
-
$19.56 B(+7.8%)
Dec 2016
$18.15 B(+0.8%)
$18.15 B(+9.0%)
Sep 2016
-
$16.65 B(+11.4%)
Jun 2016
-
$14.95 B(+14.6%)
Mar 2016
-
$13.04 B(-27.5%)
Dec 2015
$18.00 B(+41.4%)
$18.00 B(+6.1%)
Sep 2015
-
$16.96 B(+5.8%)
Jun 2015
-
$16.04 B(+15.2%)
Mar 2015
-
$13.92 B(+9.3%)
Dec 2014
$12.73 B(+108.5%)
$12.73 B(+13.2%)
Sep 2014
-
$11.25 B(+10.3%)
Jun 2014
-
$10.20 B(+31.9%)
Mar 2014
-
$7.73 B(+26.7%)
Dec 2013
$6.11 B(+64.8%)
$6.11 B(+6.5%)
Sep 2013
-
$5.74 B(+13.2%)
Jun 2013
-
$5.07 B(+17.8%)
Mar 2013
-
$4.30 B(+16.1%)
Dec 2012
$3.70 B(+108.5%)
$3.70 B(+18.0%)
Sep 2012
-
$3.14 B(+17.9%)
Jun 2012
-
$2.66 B(+22.2%)
Mar 2012
-
$2.18 B(+22.6%)
Dec 2011
$1.78 B(+50.1%)
$1.78 B(+34.4%)
Sep 2011
-
$1.32 B(-5.3%)
Jun 2011
-
$1.40 B(+5.7%)
Mar 2011
-
$1.32 B(+11.5%)
Dec 2010
$1.18 B(-40.7%)
$1.18 B(+5.5%)
Sep 2010
-
$1.12 B(-38.7%)
Jun 2010
-
$1.83 B(-31.9%)
Mar 2010
-
$2.69 B(+34.8%)
Dec 2009
$2.00 B(+564.4%)
$2.00 B(+40.5%)
Sep 2009
-
$1.42 B(+39.3%)
Jun 2009
-
$1.02 B(+51.5%)
Mar 2009
-
$672.96 M(+124.1%)
Dec 2008
$300.31 M
$300.31 M(-43.4%)
Sep 2008
-
$531.00 M(+100.0%)
Jun 2008
-
$265.44 M(-866.8%)
DateAnnualQuarterly
Mar 2008
-
-$34.62 M(-113.9%)
Dec 2007
$249.08 M(-127.9%)
$249.08 M(-304.9%)
Sep 2007
-
-$121.56 M(-76.6%)
Jun 2007
-
-$519.88 M(+4.4%)
Mar 2007
-
-$498.03 M(-44.1%)
Dec 2006
-$891.36 M(-210.1%)
-$891.36 M(-215.1%)
Sep 2006
-
$774.28 M(-6.3%)
Jun 2006
-
$826.45 M(-22.9%)
Mar 2006
-
$1.07 B(+32.4%)
Dec 2005
$809.64 M(<-9900.0%)
$809.64 M(+53.3%)
Sep 2005
-
$528.04 M(+51.4%)
Jun 2005
-
$348.81 M(+128.2%)
Mar 2005
-
$152.84 M(-3677.7%)
Dec 2004
-$4.27 M(-99.1%)
-$4.27 M(-96.3%)
Sep 2004
-
-$114.52 M(-49.7%)
Jun 2004
-
-$227.76 M(-32.9%)
Mar 2004
-
-$339.21 M(-25.2%)
Dec 2003
-$453.64 M(+18.9%)
-$453.64 M(-29.8%)
Sep 2003
-
-$646.23 M(-10.2%)
Jun 2003
-
-$719.32 M(-12.2%)
Mar 2003
-
-$819.69 M(+114.8%)
Dec 2002
-$381.64 M(-15.9%)
-$381.64 M(-8.5%)
Sep 2002
-
-$417.12 M(-4.7%)
Jun 2002
-
-$437.88 M(-4.3%)
Mar 2002
-
-$457.59 M(+0.8%)
Dec 2001
-$453.74 M(-10.3%)
-$453.74 M(-22.5%)
Sep 2001
-
-$585.31 M(+4.5%)
Jun 2001
-
-$560.12 M(+6.1%)
Mar 2001
-
-$527.73 M(+4.3%)
Dec 2000
-$506.01 M(+12.6%)
-$506.01 M(+6.1%)
Sep 2000
-
-$476.74 M(+3.8%)
Jun 2000
-
-$459.18 M(+0.9%)
Mar 2000
-
-$454.99 M(+1.3%)
Dec 1999
-$449.23 M(+17.4%)
-$449.23 M(+2.0%)
Sep 1999
-
-$440.30 M(+76.5%)
Jun 1999
-
-$249.40 M(+6.4%)
Mar 1999
-
-$234.30 M(-38.8%)
Dec 1998
-$382.70 M(+135.5%)
-$382.70 M(+89.2%)
Sep 1998
-
-$202.30 M(+9.5%)
Jun 1998
-
-$184.70 M(+8.7%)
Mar 1998
-
-$169.90 M(+4.6%)
Dec 1997
-$162.50 M(+20.8%)
-$162.50 M(+8.3%)
Sep 1997
-
-$150.10 M(+7.4%)
Jun 1997
-
-$139.70 M(-1.9%)
Mar 1997
-
-$142.40 M(+5.9%)
Dec 1996
-$134.50 M(+19.2%)
-$134.50 M(+6.4%)
Sep 1996
-
-$126.40 M(-6.9%)
Jun 1996
-
-$135.70 M(+9.8%)
Mar 1996
-
-$123.60 M(+21.5%)
Dec 1995
-$112.80 M(+32.2%)
-
Sep 1995
-
-$101.70 M(+9.0%)
Jun 1995
-
-$93.30 M(+9.4%)
Mar 1995
-
-$85.30 M(+11.5%)
Mar 1995
-$85.30 M(+57.7%)
-
Dec 1994
-
-$76.50 M(+12.0%)
Sep 1994
-
-$68.30 M(+11.6%)
Jun 1994
-
-$61.20 M(+13.1%)
Mar 1994
-$54.10 M(+90.5%)
-$54.10 M(+18.4%)
Dec 1993
-
-$45.70 M(+17.5%)
Sep 1993
-
-$38.90 M(+17.5%)
Jun 1993
-
-$33.10 M(+16.5%)
Mar 1993
-$28.40 M(+98.6%)
-$28.40 M(+25.7%)
Dec 1992
-
-$22.60 M(+20.2%)
Sep 1992
-
-$18.80 M(+17.5%)
Jun 1992
-
-$16.00 M(+11.9%)
Mar 1992
-$14.30 M(+45.9%)
-$14.30 M(+45.9%)
Mar 1991
-$9.80 M
-$9.80 M

FAQ

  • What is the all time high annual retained earnings for Gilead Sciences?
  • What is the all time high quarterly retained earnings for Gilead Sciences?

What is the all time high annual retained earnings for Gilead Sciences?

Gilead Sciences all-time high annual retained earnings is $19.39 B

What is the all time high quarterly retained earnings for Gilead Sciences?

Gilead Sciences all-time high quarterly retained earnings is $23.69 B